|
|
||||||||
1 Institute of Physiology, University of Rostock, D-18055 Rostock, Germany; and 2 Institute of Experimental Cardiology, Cardiology Research Center, Academy of Medical Sciences, 121552 Moscow, Russia
| |
ABSTRACT |
|---|
|
|
|---|
The hypothesis that protein kinase C (PKC) is able to regulate the whole cell Ca-activated K (KCa) current independently of PKC effects on local Ca release events was tested using the patch-clamp technique and freshly isolated rat tail artery smooth muscle cells dialyzed with a strongly buffered low-Ca solution. The active diacylglycerol analog 1,2-dioctanoyl-sn-glycerol (DOG) at 10 µM attenuated the current-voltage (I-V) relationship of the KCa current significantly and reduced the KCa current at +70 mV by 70 ± 4% (n = 14). In contrast, 10 µM DOG after pretreatment of the cells with 1 µM calphostin C or 1 µM PKC inhibitor peptide, selective PKC inhibitors, and 10 µM 1,3-dioctanoyl-sn-glycerol, an inactive diacylglycerol analog, did not significantly alter the KCa current. Furthermore, the catalytic subunit of PKC (PKCC) at 0.1 U/ml attenuated the I-V relationship of the KCa current significantly, reduced the KCa current at +70 mV by 44 ± 3% (n = 17), and inhibited the activity of single KCa channels at 0 mV by 79 ± 9% (n = 6). In contrast, 0.1 U/ml heat-inactivated PKCC did not significantly alter the KCa current or the activity of single KCa channels. Thus these results suggest that PKC is able to considerably attenuate the KCa current of freshly isolated rat tail artery smooth muscle cells independently of effects of PKC on local Ca release events, most likely by a direct effect on the KCa channel.
catalytic subunit of protein kinase C; calcium-activated potassium channel; local calcium release
| |
INTRODUCTION |
|---|
|
|
|---|
THE CALCIUM-ACTIVATED potassium
(KCa) channel has been
identified in all vascular smooth muscle cells investigated so far. The
K current carried by KCa channels
is one of the major outward currents of vascular smooth muscle cells.
Recently, it has been shown that in arteries exposed to a physiological
pressure level but not subjected to any vasoactive agonist this current
belongs to the ion currents that establish the membrane potential, one of the main factors determining the contractile state of these arteries
(5). Thus the contractile state of these arteries may be altered by
either an increase of the KCa
current, leading to membrane potential hyperpolarization and
vasodilation, or by a decrease of the
KCa current, leading to membrane
potential depolarization and vasoconstriction. Indeed, an increase of
the arterial KCa current has been
shown to be important, for example, for the protein kinase G
(PKG)-mediated vasodilation induced by NO (2) and estrogen (28) as well
as for the protein kinase A (PKA)-mediated vasodilation induced by
iloprost (23). Furthermore, a decrease of the arterial
KCa current has been shown to be
important for the vasoconstriction induced by
20-hydroxy-(5Z,8Z,11Z,14Z)-eicosatetraenoic acid (30). However, in
contrast to numerous studies showing that vasodilations accompanied by
an increase of the KCa current are
mediated by intracellular messengers like PKA and PKG, the intracellular messengers mediating vasoconstrictions accompanied by a
decrease of the KCa current are
not well known. Yet, recent reports showing that another K current, the
ATP-sensitive K current, is involved in the vasoconstriction induced by
2D receptor agonists (26) and
that the decrease of this current produced by neuropeptide Y,
phenylephrine, serotonin, and histamine (4) is mediated by protein
kinase C (PKC) suggest that PKC may be an intracellular messenger
mediating vasoconstrictions accompanied by a decrease of the
KCa current. This hypothesis is
supported by recent findings demonstrating that spontaneous transient
outward currents, which represent
KCa currents induced by local Ca
release events, are inhibited by a PKC-mediated depletion of Ca stores
in rabbit portal vein (13) or by a PKC-mediated inhibition of ryanodine
receptor channel activity in rat cerebral arteries (3). In the latter study, it was additionally suggested that the PKC-mediated decrease of
the arterial smooth muscle KCa
current may be caused by some other mechanisms unrelated to local Ca
release events. Thus an inhibition of
KCa channels by PKC was proposed,
although this question had not been studied in detail (3). This
hypothesis is supported by the observation that activators of PKC can
inhibit the activity of single KCa
channels in cultured porcine coronary artery smooth muscle cells (18).
However, considerable alterations can occur in cultured smooth muscle
cells in comparison with native cells, including the appearance of
KCa channels with atypical properties (25) and the disappearance of
KCa channels (8). Thus the aim of
this study was to explore in more detail the possibility that a
PKC-mediated decrease of the arterial smooth muscle
KCa current may be produced, at
least partly, independently of effects of PKC on local Ca release
events. To accomplish this, experiments were performed to investigate
the effect of an activation of endogenous PKC by a diacylglycerol
analog, 1,2-dioctanoyl-sn-glycerol
(DOG), and of the application of PKC on the whole cell
KCa current of freshly isolated
arterial smooth muscle cells dialyzed with a strongly Ca-buffered
solution to eliminate local Ca release events as well as the effect of
the application of PKC on excised single KCa channels of these cells.
| |
METHODS |
|---|
|
|
|---|
Cell isolation and solutions.
Tail arteries were obtained from male Wistar-Kyoto rats, which were
killed by stunning and subsequent decapitation. A 2- to 3-cm-long piece
of an artery was placed into a microtube containing 1 ml of an enzyme
solution and stored there overnight at 4°C. The enzyme solution
contained (in mM) 110 NaCl, 5 KCl, 0.16 CaCl2, 2 MgCl2, 10 NaHEPES, 10 NaHCO3, 0.5 KH2PO4,
0.5 NaH2PO4,
10 glucose, 0.49 EDTA, and 10 taurine at pH 7.0, and also 1.5 mg/ml
papain (12,000 U/g), 1.6 mg/ml albumin, and 0.4 mg/ml
DL-dithiothreitol. The next day,
the microtube with the vessel was incubated for 5-10 min at
37°C. Single cells were released by trituration with a polyethylene
pipette into the experimental bath solution. The experimental bath
solution in the whole cell experiments contained (in mM) 135 NaCl, 6 KCl, 0.1 CaCl2, 1 MgCl2, 3 EGTA (purity 96%), and
10 HEPES at pH 7.4, with a calculated free Ca concentration of ~3 × 10
9 M. The
experimental bath solution in the inside-out experiments contained (in
mM) 140 KCl, 3 EGTA (purity 96%), 3 HEDTA (purity 98%), an
appropriate amount of MgCl2 to get
a free Mg concentration of 1 mM, an appropriate amount of
CaCl2 to get the desired free Ca
concentration, and 10 HEPES at pH 7.4. For a first estimate of the free
Ca concentrations, solution composition was calculated with the
following apparent reaction constants
(K) at pH 7.4: log
KCaEGTA = 7.17, log KMgEGTA = 1.93, log
KCaHEDTA = 5.67, and log KMgHEDTA = 4.37 (21). The exact free Ca concentration in the bath solution for
the inside-out experiments was measured using fura 2, and, after
calibration of the signal with K-based standard solutions (CALBUF-2;
World Precision Instruments), a concentration of 2.5 µM was
determined. The pipette solution contained (in mM) 102 KCl, 10 NaCl, 1 CaCl2, 1 MgCl2, 10 EGTA (purity 96%) or 10 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic
acid (BAPTA; purity 98%), 10 HEPES, and 0.1 MgATP at pH 7.4, with a calculated free Ca concentration of ~8 × 10
9 M in the whole cell
experiments and 135 NaCl, 6 KCl, 1 CaCl2, 1 MgCl2, and 10 HEPES at pH 7.4 in
the inside-out experiments.
Patch-clamp recordings.
All patch-clamp experiments were performed at room temperature
(22-24°C). Patch pipettes were prepared from borosilicate
glass (WP Instruments) and had a resistance in the range of 1-3
M
when filled with the pipette solution. Recordings were made with
an Axopatch 200 amplifier (Axon Instruments) with the conventional whole cell and inside-out configuration.
Whole cell experiments.
In the whole cell experiments, stimulation of currents with pulse and
ramp protocols, data sampling at a rate of 1 kHz for ion currents and
of 50 kHz for cell capacitance and series resistance determination, and
data analysis were all done with the software package ISO2 (MFK).
Experiments were performed only on cells with negligible leaks. Series
resistance compensation was not employed because often cells were lost
even at slight overcompensation. Instead, series resistance was
measured every 2 min during the course of the experiment. Data were
used for analysis if the command voltage error due to series resistance
changed <2 mV. In a few cases, a voltage error change of 5 mV was
accepted, but these data were corrected using the current-voltage
(I-V)
relationship obtained during ramp pulses. Whole cell currents were
elicited every 5 s by either 500-ms step pulses from a holding
potential of
40 mV to a test potential of +70 mV or by 1,000-ms
ramp pulses from
70 to +100 mV. Current amplitudes were either
determined from step pulse stimulation and measured as the mean current
of the last 100 ms of the average of three consecutive current traces or determined from ramp pulse stimulation at the desired potentials. Preliminary tests showed that the current amplitudes at a certain potential obtained from consecutive step pulse and ramp pulse stimulations do not differ significantly. The difference in command potential to obtain the same current amplitude with ramp pulse stimulation compared with step pulse stimulation at +70 mV was only 1.8 ± 0.3 mV (n = 34).
Isolation of the KCa current. The KCa current was defined as the difference of the net outward current amplitude under the desired condition, e.g., control or PKC application, and the outward current amplitude after application of 100 nM iberiotoxin, the specific inhibitor of KCa channels (9, 10), which was given at the end of each experiment. The correctness of this procedure was proven by the observation that the iberiotoxin-resistant currents after the application of DOG or PKC were not significantly different from the currents without application of any substance (data not shown). The threshold potential of the KCa current was determined as the potential of the intercept of the I-V relationships of the KCa current before and after iberiotoxin application. To be able to test the hypothesis that PKC may have an effect on the KCa current independently of effects of PKC on local Ca release events, freshly isolated arterial smooth muscle cells were dialyzed with a strongly Ca-buffered solution to eliminate local Ca release events. Two ligands were employed to buffer the intracellular Ca concentration, EGTA, a widely used Ca buffer, and BAPTA, a Ca buffer with fast binding kinetics. Under these conditions, it was observed that the control KCa current at +70 mV after 6 min was 87 ± 11% (n = 5) of the current at the beginning of the registration period when 10 mM EGTA was used in the intracellular solution and 93 ± 8% (n = 4) of the current at the beginning of the registration period when 10 mM BAPTA was used in the intracellular solution, which are not significantly different (P = 0.69). The active diacylglycerol analog DOG at 10 µM decreased the KCa current 6 min after the beginning of the application at +70 mV by 70 ± 4% (n = 8) compared with the current at the beginning of the application period when 10 mM EGTA was used in the intracellular solution and by 69 ± 8% (n = 6) compared with the current at the beginning of the application period when 10 mM BAPTA was used in the intracellular solution, which are not significantly different (P = 0.84). The catalytic subunit of PKC (PKCC) at 0.1 U/ml decreased the KCa current 6 min after the beginning of the application at +70 mV by 47 ± 5% (n = 10) compared with the current at the beginning of the application period when 10 mM EGTA was used in the intracellular solution and by 40 ± 3% (n = 7) compared with the current at the beginning of the application period when 10 mM BAPTA was used in the intracellular solution, which are not significantly different (P = 0.28). Because there were no significant differences of the effect of DOG and PKCC on the KCa current in the experiments using EGTA or BAPTA, respectively, in the intracellular solution, these data were pooled. In addition to the independence of the observed results from the Ca buffer used in the intracellular solution, further evidence for a successful elimination of local Ca release events under our experimental conditions are the inability to observe spontaneous transient outward currents and the absence of an effect of ryanodine, a well-known blocker of local Ca release events, and of cyclopiazonic acid, an inhibitor of the Ca pump in the sarcoplasmic reticulum, on the KCa current. Thus 10 µM ryanodine decreased the KCa current 6 min after the beginning of the application at +70 mV by 3 ± 6% (n = 7) compared with the current at the beginning of the application period. This is not significantly different from the 10 ± 7% (n = 9) decrease of the time-matched control current at +70 mV (P = 0.43). Furthermore, 10 µM cyclopiazonic acid increased the KCa current 6 min after the beginning of the application at +70 mV by 2 ± 7% (n = 9) compared with the current at the beginning of the application period. This is not significantly different from the 10 ± 7% (n = 9) decrease of the time-matched control current at +70 mV (P = 0.22).
Inside-out experiments. In the inside-out experiments, single-channel data were stored on a DTR-1800 data recorder (Biologic, France) and later replayed for analysis. They were filtered at 1 kHz with use of an eight-pole Bessel filter (model 902, Frequency Devices, USA) and digitized at 5 kHz. Thereafter, they were analyzed offline with the software package ASCD (G. Droogmans, Lab. Fysiologie, KU Leuven, Louvain, Belgium). The single-channel amplitudes were determined by fitting Gaussian distributions to the amplitude histograms of the closed and the open state, respectively. The activity of the channel in a patch was determined as NPo, where Po is the open probability of one channel and N is the number of channels in the patch, which could not be determined in most cases because the patch was lost before application of a high-Ca solution. NPo was calculated as the sum of the times finding 1, 2, 3, · · · , N simultaneously open channels divided by the registration time. The registration time was 2-3 min in the control and 3-5 min during PKC and PKC inhibitor peptide application. All potentials are expressed as membrane potentials.
Drugs and chemicals.
Albumin, DL-dithiothreitol, and
the salts for the solutions were obtained from Sigma, except for BAPTA,
which was purchased from Molecular Probes. Papain was from Ferak
(Berlin, Germany). Iberiotoxin and ryanodine were from Research
Biochemicals International. PKCC,
the PKC inhibitor peptide (19
31), DOG, and calphostin C were obtained
from Calbiochem, and
1,3-dioctanoyl-sn-glycerol was from Biomol.
Statistics. All data are presented as means ± SE; n is the number of cells. Statistical analysis was performed with use of paired and unpaired t-tests, one-way ANOVA followed by a Bonferroni test, or repeated measures ANOVA, as appropriate.
| |
RESULTS |
|---|
|
|
|---|
In a recent publication, we characterized the properties of the outward current of rat tail artery smooth muscle cells in detail (22). Briefly, this current showed a marked outward rectification, a strong dependence on the intracellular Ca ion concentration, and a high sensitivity to iberiotoxin, the selective blocker of KCa channels (9, 10), which produced a considerable inhibition of this current. Neither glibenclamide, the selective blocker of ATP-sensitive K channels, nor 4-aminopyridine, a blocker of voltage-dependent K channels, affected this current. Additionally, it was shown in the cited publication that in excised patches from these cells a K channel with a high conductance, a steep voltage dependence of activation, and a prominent Ca sensitivity is the main channel, which was blocked by low concentrations of tetraethylammonium and by iberiotoxin. Thus, under our experimental conditions, the outward current of these cells consists largely of a KCa current, which is carried by KCa channels. The KCa current in the present study was defined as the difference of the net outward current amplitude under the desired experimental condition and the outward current amplitude after application of 100 nM iberiotoxin and was independent from local Ca release events (for details, see Isolation of the KCa current, above).
Effect of an activation of PKC on the KCa
current.
For the investigation of the effect of PKC on the
KCa current of rat tail artery
smooth muscle cells, DOG (7), a cell-permeable active analog of
diacylglycerol, was used to activate PKC. DOG at a concentration of 10 µM was applied to the bath solution 2 min after the whole cell
configuration was obtained. Control experiments had shown that this
time was necessary but sufficient to get stable currents (data not
shown). Therefore, the beginning of any application period was marked
time
0. A typical example of the time
course of the KCa current elicited
with use of a voltage step from a holding potential of
40 mV to
a test potential of +70 mV under control conditions and after DOG
application is shown in Fig. 1A.
A transient increase of the KCa
current was observed ~1-2 min after the beginning
of DOG application. This increase did not reach significance in
comparison with the time-matched control current and was, therefore,
not studied in detail. Subsequently, the
KCa current started to decline,
and 6-8 min after the beginning of DOG application, the
KCa current reached a steady state
at a considerably lower level compared with the time-matched control current. For example, in the control series, the
KCa current elicited with use of a
voltage step from a holding potential of
40 mV to a test
potential of +70 mV was 131 pA at the beginning of the control
application period and 99 pA 6 min after the beginning of the control
application period (Fig. 1B,
top).
I-V
relationships of the control KCa
current were obtained with use of a voltage ramp from
70 mV to
+100 mV based on a holding potential of
40 mV and showed that
the changes of the control current with time were similar at all
potentials tested (see Fig. 1B,
bottom, for a typical example). In
contrast, in the DOG series, the
KCa current elicited with use of a
voltage step from a holding potential of
40 mV to a test
potential of +70 mV was, for example, 214 pA at the beginning of the
DOG application period and only 33 pA 6 min after the beginning of the
DOG application period (Fig. 1C,
top).
I-V
relationships of the KCa current
obtained with use of a voltage ramp from
70 mV to +100 mV based
on a holding potential of
40 mV showed that DOG produced a
marked decrease of the KCa current
in the potential range tested. This is demonstrated in Fig.
1C,
bottom, with a typical example and, in
addition to the original traces, the
I-V
relationship of the pure KCa
current, i.e., the difference of the net outward current and the
iberiotoxin-insensitive current, is shown before and after DOG
application (Fig. 1C,
bottom right). In summary, the
I-V
relationship of the KCa current
was altered significantly, seen as a reduction of this current (Fig. 2), and the threshold potential of the
current changed significantly, from 23.6 ± 3.4 to 40.0 ± 2.9 mV
or by 16.4 ± 2.8 mV (n = 7;
P < 0.01). On average, 10 µM DOG
decreased the KCa current 6 min after the beginning of the application at +70 mV by 70 ± 4%
(n = 14) compared with the current at
the beginning of the application period. This is a significant decrease
in comparison with the 10 ± 7% (n = 9) decrease of the time-matched control current at +70 mV (see Fig.
4; P < 0.001).
|
|
40 mV to a test
potential of +70 mV after calphostin C application is shown in Fig.
3A,
together with an example of the time course of the
KCa current after DOG application with calphostin C pretreatment and after DOG application without PKC
blocker pretreatment. During the application of 10 µM DOG to cells
pretreated with 1 µM calphostin C, the
KCa current was measured with the
same protocol as in the DOG series. An increase of the
KCa current was observed ~2 min
after the beginning of DOG application, but subsequently there was no
decline of the KCa current;
rather, the KCa current stayed at
the increased level. For example, in the experiments with calphostin C
pretreatment, the KCa current
elicited with use of a voltage step from a holding potential of
40 mV to a test potential of +70 mV was 682 pA at the beginning
of the DOG application period and 779 pA 6 min after the beginning of
the DOG application period (Fig. 3B,
top).
I-V relationships of the KCa current
obtained with use of a voltage ramp from
70 mV to +100 mV based
on a holding potential of
40 mV showed that DOG after calphostin
C pretreatment produced a small increase of the
KCa current at all potentials
tested (see Fig. 3B,
bottom, for a typical example). In
summary, 10 µM DOG after calphostin C pretreatment increased the
KCa current 6 min after the
beginning of the application at +70 mV by 5 ± 8%
(n = 6) compared with the current at
the beginning of the application period. This is significantly
different from the 70 ± 4% (n = 14; P < 0.001) decrease of the
KCa current after DOG application without PKC blocker pretreatment at +70 mV (Fig.
4).
|
|
31), another selective PKC
inhibitor, on the DOG effect was tested. PKC inhibitor peptide at a
concentration of 1 µM was added to the pipette solution. Control
experiments showed that PKC inhibitor peptide itself did not affect the
KCa current (Fig. 4). In summary, 10 µM DOG after PKC inhibitor peptide pretreatment increased the KCa current 6 min after the
beginning of the application at +70 mV by 3 ± 16%
(n = 5) compared with the current at
the beginning of the application period. This is significantly
different from the 70 ± 4% (n = 14; P < 0.001) decrease of the
KCa current after DOG application
without PKC blocker pretreatment at +70 mV (Fig. 4).
To test for a possible nonspecific effect of DOG on the
KCa current, the effect of
1,3-dioctanoyl-sn-glycerol (inactive
DOG), a cell-permeable inactive analog of diacylglycerol, was tested. A
typical example of the time course of the
KCa current elicited with use of a
voltage step from a holding potential of
40 mV to a test
potential of +70 mV after application of inactive DOG is shown in Fig.
1A, together with an example of the
time course of the KCa current
after DOG application and of the control
KCa current. During the
application of 10 µM inactive DOG, the
KCa current was measured with the
same protocol as in the DOG series. An increase of the
KCa current was observed 2 min
after the beginning of application of inactive DOG, and subsequently
there was no decline of the KCa
current; rather, the KCa current
stayed at the increased level. In summary, 10 µM inactive DOG
increased the KCa current 6 min
after the beginning of the application at +70 mV by 18 ± 10%
(n = 4) compared with the current at
the beginning of the application period. This is significantly
different from the 70 ± 4% (n = 14; P < 0.001) decrease of the
KCa current after DOG application
at +70 mV (Fig. 4).
Effect of PKC on the KCa current.
For the further investigation of the effect of PKC on the
KCa current of rat tail artery
smooth muscle cells, PKCC (27), which is active in the absence of phospholipids and Ca, was employed. PKCC was added to the pipette
solution at 0.1 U/ml. A higher activity of
PKCC was not used so as to avoid
possible artifacts caused by components of the
PKCC storage buffer. A typical
example of the time course of the
KCa current elicited with use of a
voltage step from a holding potential of
40 mV to a test
potential of +70 mV under control conditions and after
PKCC application is shown in Fig.
5A. The
KCa current started to decline
~3-4 min after the beginning of
PKCC application, and 6-8 min
after the beginning of PKCC
application the KCa current
reached a steady state at a considerably lower level compared with the
time-matched control current. For example, the
KCa current elicited with use of a
voltage step from a holding potential of
40 mV to a test potential of +70 mV was 209 pA at the beginning of the
PKCC application period and only
79 pA 6 min after the beginning of the
PKCC application period (Fig.
5B,
top).
I-V
relationships of the KCa current
obtained with use of a voltage ramp from
70 mV to +100 mV based
on a holding potential of
40 mV showed that
PKCC produced a marked decrease of
the KCa current in the potential
range tested. This is demonstrated in Fig.
5B,
bottom, with a typical example and, in
addition to the original traces, the
I-V
relationship of the pure KCa
current, i.e., the difference of the net outward current and the
iberiotoxin-insensitive current, is shown before and after
PKCC application (Fig.
5B, bottom
right). In summary, the
I-V
relationship of the KCa current was altered significantly, seen as a reduction of this current (Fig.
6), and the threshold potential of the
current changed significantly, from 30.0 ± 2.2 to 41.1 ± 2.2 mV
or by 11.1 ± 2.0 mV (n = 9;
P < 0.01). On average, 0.1 U/ml
PKCC decreased the
KCa current 6 min after the
beginning of the application at +70 mV by 44 ± 3% (n = 17) compared with the current at
the beginning of the application period. This is a significant decrease
in comparison with the 10 ± 7% (n = 9) decrease of the time-matched control current at +70 mV (see Fig.
8; P < 0.01).
|
|
40 mV to a
test potential of +70 mV after application of heat-inactivated
PKCC is shown in Fig.
7A,
together with an example of the time course of the
KCa current after application of
active PKCC. However, there was no change of the KCa current during
the whole application period. For example, the
KCa current elicited with use of a
voltage step from a holding potential of
40 mV to a test
potential of +70 mV was 184 pA at the beginning of the application
period of heat-inactivated PKCC
and 152 pA 6 min after the beginning of the application period (Fig.
7B,
top).
I-V
relationships of the KCa current
obtained with use of a voltage ramp from
70 mV to +100 mV based
on a holding potential of
40 mV showed that the changes of the
control current with time were similar at all potentials tested (see
Fig. 7B, bottom, for a typical example). In
summary, 0.1 U/ml heat-inactivated PKCC decreased the
KCa current 6 min after the
beginning of the application at +70 mV by 13 ± 9%
(n = 5) compared with the current at
the beginning of the application period. This is significantly different from the 44 ± 3% (n = 17; P < 0.01) decrease of the KCa current after application of
active PKCC at +70 mV (Fig.
8).
|
|
Effect of PKC on single KCa channels.
For the investigation of the effect of PKC on the
KCa current of rat tail artery
smooth muscle cells, the direct effect of PKCC on single
KCa channels was tested.
PKCC was added to the bath
solution at 0.1 U/ml together with 100 µM MgATP after the registration of channel control activity. In these single-channel experiments, a spontaneous decrease of the activity of the
KCa channel (rundown) was often
observed, the nature of which was not established in the present study.
Therefore, all measurements showing a rundown in the registration of
channel control activity were excluded from further analysis.
Furthermore, to be able to differentiate the expected PKC-induced
decrease of KCa channel activity
from rundown, the experimental protocol included a test of the action
of PKC inhibitor peptide after a stable level of channel activity was
obtained after PKC application. Only experiments in which PKC inhibitor
peptide was able to reverse the effect of PKC on the
KCa current were included in the
analysis. A typical example of the time course of the activity of
single KCa channels at 0 mV under
control conditions and after PKCC
and subsequent PKC inhibitor peptide application is shown in Fig.
9A.
KCa channel activity started to
decline ~2 min after the beginning of the application of
PKCC together with 100 µM MgATP,
and KCa channel activity reached a
steady state ~4 min after the beginning of PKCC application. Subsequently,
PKC inhibitor peptide application restored
KCa channel activity, and, ~3
min after the beginning of PKC inhibitor peptide application,
KCa channel activity reached a
steady state. In this example (Fig.
9B),
KCa channel activity (NPo) at 0 mV
was 0.56 in the control period, 0.07 during the steady state after
PKCC application, and 0.51 during
the steady state after the subsequent addition of PKC inhibitor
peptide. On average, 0.1 U/ml PKCC
together with 100 µM MgATP decreased KCa channel activity in the steady
state at +0 mV significantly by 79 ± 9%
(n = 6) compared with the activity in
the control period (Fig. 9C;
P < 0.001). PKC inhibitor peptide
reversed the PKCC-induced decrease
of KCa channel activity, and in
the steady state a nonsignificant decrease of channel activity by 5 ± 22% (n = 6) compared with the
activity in the control period was observed (Fig.
9C; P = 0.82). The amplitude of single
KCa channel openings was not
changed after the addition of PKCC
or PKC inhibitor peptide (data not shown).
|
| |
DISCUSSION |
|---|
|
|
|---|
Effect of an activation of PKC on the KCa current of rat tail artery smooth muscle cells. The aim of the first series of experiments was to investigate the effect of an activation of the endogenous PKC on the KCa current. To activate PKC, an active analog of the natural PKC activator diacylglycerol, DOG, was used (7). In the present experiments, the PKC activator DOG entered the cells from the extracellular space, in contrast to the natural conditions, in which the PKC activator is released from membrane phospholipids. Therefore, it was necessary to obtain evidence that the effect of DOG on the KCa current is mediated by PKC. In the present study the DOG-induced decrease of the KCa current was completely blocked by the specific PKC inhibitors calphostin C and PKC inhibitor peptide. Calphostin C acts by an interaction with the diacylglycerol binding site of the regulatory domain of PKC (14), and PKC inhibitor peptide acts as pseudo-substrate by binding to the active site of PKC. An unspecific action of DOG on the KCa current seems unlikely also because the inactive diacylglycerol analog 1,3-dioctanoyl-sn-glycerol was unable to reduce the KCa current. Therefore, the decrease of the KCa current induced by DOG is probably mediated by an activation of the PKC present in these cells.
Interestingly, in recent publications it has been shown that DOG decreases the ATP-sensitive K current in rabbit mesenteric artery smooth muscle cells (4) and the voltage-dependent K current in rabbit portal vein smooth muscle cells (1) and that the latter effect was blocked by calphostin C. Additionally, phorbol ester decreased spontaneous transient outward K currents, which are generated by the action of spontaneously released Ca from intracellular stores on KCa channels, in rabbit portal vein smooth muscle cells, and this effect was also blocked by inhibition of PKC (13). Furthermore, a phorbol ester-mediated decrease of KCa currents was also observed in cultured endothelial cells (29) and in rat pituitary tumor cells (24). In summary, our data show that the KCa current of rat tail artery smooth muscle cells can be inhibited by an activation of the endogenous PKC of these cells.Effect of PKC on the KCa current and single KCa channels of rat tail artery smooth muscle cells. The aim of the second series of experiments was to investigate the effect of exogenous PKC on the KCa current and on single KCa channels. To ensure a straightforward interpretation of these experiments, PKCC was used, which does not require Ca or phosphatidylserine to be active (27). Thus the number of factors that could affect the KCa current or KCa channel on their own was limited. In the present study, it was shown for the first time that the application of PKCC together with MgATP, which was permanently present in the intracellular solution in all experiments, considerably decreased the KCa current in freshly isolated arterial smooth muscle cells. Furthermore, the data on the direct inhibition of single-KCa channel activity by PKCC together with MgATP in freshly isolated smooth muscle cells extend earlier findings showing an inhibition of single KCa channel activity in cultured smooth muscle cells from porcine coronary arteries after a direct application of PKC to this channel (18).
It should be noted that the PKC storage buffer contained a variety of components, for example, 100 mM NaCl, 15 mM dithiothreitol, and 10% glycerol, some of which are known to affect KCa channel function. Therefore, the PKC stock solution was diluted 100 times to avoid artifacts caused by the components of the PKC storage buffer. This, however, limited the maximal employable PKC activity to 0.1 U/ml and, consequently, it was decided not to use higher activities of PKC to test whether or not PKC is able to inhibit the KCa current completely. To obtain evidence for a specific action of PKC on the KCa current and the KCa channel, the PKC stock solution was heated for 30 min at 60°C. Application of solution containing heat-treated PKC did not produce any effect on the KCa current or the KCa channel, demonstrating that a heat-sensitive component in the PKC stock solution, probably the protein PKC, is responsible for the decrease of the KCa current and KCa channel activity. In summary, the present data show that the KCa current and the activity of KCa channels of freshly isolated rat tail artery smooth muscle cells can be inhibited by exogenous PKC, supporting earlier conclusions that this current can be inhibited by an activation of the endogenous PKC.Mechanism of the PKC effect on the KCa current of rat tail artery smooth muscle cells. When discussing the mechanism of the PKC effect on the KCa current, it is important to note that in whole cell experiments the KCa current has been shown to be influenced markedly by changes of the intracellular Ca concentration induced by the inositol trisphosphate-mediated Ca release (13), the ryanodine-sensitive Ca release (19), or the Na/Ca exchange (6). The activity of these mechanisms regulating the intracellular Ca ion concentration is also affected by PKC (3, 15). Therefore, specific experimental conditions with a strongly buffered low intracellular Ca concentration and a low extracellular Ca concentration were selected, which have been shown to greatly reduce the influence of mechanisms regulating the intracellular Ca concentration on the KCa current (6). The absence of an effect of ryanodine, which blocks local Ca release events spontaneously occurring even in resting cells, on the KCa current demonstrated that under the selected experimental conditions it was possible to investigate the effect of PKC on the KCa current under conditions of a minimized influence of alterations of the intracellular Ca concentration.
Because the whole cell KCa current equals the product of N, Po, and single-channel amplitude, the observed decrease of the KCa current may be caused by a decrease of any one of these factors. The whole cell data of the present study show that DOG as well as PKC produce a larger reduction of the KCa current at lower compared with higher membrane potentials and a significant shift of the current threshold. This indicates that PKC affects mainly the Po of the KCa channel. Indeed, the experiments on the effect of PKC on single KCa channels demonstrated that PKC does not affect the single-channel amplitude or N but considerably alters the Po. Thus, under the conditions of the present study, PKC inhibits the KCa current by a direct interaction with the channel or a closely related protein leading to a decrease of single-channel activity. As mentioned above, under more physiological conditions of extracellular and intracellular Ca concentrations, PKC could affect the KCa current also by an alteration of the activity of mechanisms regulating the intracellular Ca concentration. Therefore, as in the recent study on the regulation of the KCa current by ryanodine receptor channel-dependent Ca release events (3), it should be investigated whether the KCa current is additionally affected by a PKC-mediated effect on, for example, the Ca pump in the sarcoplasmic reticulum, the Ca pump in the plasmalemma, the Ca channel in the plasmalemma, or the Na/Ca exchange. Because of this multitude of possibilities, this question, however, should be addressed in a separate study.Possible functional role of the PKC effect on the KCa current of rat tail artery smooth muscle cells. Because the KCa current in a variety of arterial smooth muscle cells in vessels exposed to a physiological pressure level but not subjected to any vasoactive agonist belongs to the ion currents establishing the membrane potential (5), a PKC-mediated decrease of this current may have important functional consequences. Thus a decrease of the KCa current, leading to membrane potential depolarization and vasoconstriction, may mediate the effect of transmural pressure or of different vasoconstrictors, because these stimuli have been shown to activate PKC (12, 15). However, the hypothesis of a functional importance of the PKC-mediated decrease of the vascular smooth muscle KCa current is highly speculative at the moment. Thus a phospholipase C-induced activation of PKC under physiological conditions is accompanied by an inositol trisphosphate-mediated release of Ca from intracellular stores. This Ca may increase the KCa current and, therefore, counteract its decrease by PKC. Additionally, the regulation of the KCa current by PKC-dependent local Ca release events has to be taken into account (3). The data available do not allow estimation of the net effect of the simultaneous action of Ca and PKC on the KCa current. Furthermore, PKC alters the activity of several other mechanisms, which also can produce vessel constriction. Limiting this consideration only to mechanisms regulating the membrane potential, PKC, for example, decreases the ATP-sensitive K current (4) and the voltage-dependent K current (1) and increases the voltage-dependent Ca current (16). Again, the data available do not allow estimation of whether the PKC-related response to the above-mentioned physiological stimuli is mediated mainly by the PKC-induced decrease of the KCa current or mainly by one of the other mechanisms. Additionally, although the membrane potential and the intracellular Ca concentration can be adjusted in patch-clamp experiments to simulate physiological conditions for the KCa channel, the functional state of a variety of other factors affecting its function is quite different in an intact artery compared with an isolated cell, e.g., PKA is activated by transmural pressure (11), PKG is activated by flow-induced release of NO (20), or G proteins are activated by epoxyeicosatrienoic acids (17). Moreover, their functional state in the intact artery is not known and, therefore, cannot be simulated in an isolated cell. Thus the functional role of the PKC effect on the KCa current can be established only in studies on intact vessel preparations. In conclusion, the complete mechanism and the functional role of the PKC-induced regulation of the KCa current have to be established in future studies.
In summary, this study presents the novel observation that the KCa current of freshly isolated rat tail artery smooth muscle cells was decreased by PKCC and by an active analog of diacylglycerol, an activator of PKC, independently of their effects on local Ca release events. The effect of the active analog of diacylglycerol was inhibited by calphostin C and PKC inhibitor peptide, selective PKC inhibitors, and was not mimicked by an inactive analog of diacylglycerol, providing evidence for a PKC-selective action of the diacylglycerol analog. Furthermore, the finding of the present study that the activity of single KCa channels was decreased by PKCC in freshly isolated vascular smooth muscle cells suggests that the effect of PKC on KCa currents is mediated by its direct action on the channel.| |
ACKNOWLEDGEMENTS |
|---|
This research was supported by Deutsche Forschungsgemeinschaft Grant 436 RUS 113/11 (to R. Schubert), a University of Rostock Research Grant (to R. Schubert), and Russian Foundation for Basic Research Grant 98-04-04106 (to V. Serebryakov).
| |
FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests: R. Schubert, University of Rostock, Institute of Physiology, PSF 100888, D-18055 Rostock, Germany.
Received 9 March 1998; accepted in final form 2 December 1998.
| |
REFERENCES |
|---|
|
|
|---|
1.
Aiello, E. A.,
O. Clement-Chomienne,
D. P. Sontag,
M. P. Walsh,
and
W. C. Cole.
Protein kinase C inhibits delayed rectifier K+ current in rabbit vascular smooth muscle cells.
Am. J. Physiol.
271 (Heart Circ. Physiol. 40):
H109-H119,
1996
2.
Archer, S. L.,
J. M. C. Huang,
V. Hampl,
D. P. Nelson,
P. J. Shultz,
and
E. K. Weir.
Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase.
Proc. Natl. Acad. Sci. USA
91:
7583-7587,
1994
3.
Bonev, A.,
and
M. T. Nelson.
Vasoconstrictors inhibit ATP-sensitive K+ channels in arterial smooth muscle through protein kinase C.
J. Gen. Physiol.
108:
315-323,
1996
4.
Bonev, A. D.,
J. H. Jaggar,
M. Rubart,
and
M. T. Nelson.
Activators of protein kinase C decrease Ca2+ spark frequency in smooth muscle cells from cerebral arteries.
Am. J. Physiol.
273 (Cell Physiol. 42):
C2090-C2095,
1997
5.
Brayden, J. E.,
and
M. T. Nelson.
Regulation of arterial tone by activation of calcium-dependent potassium channels.
Science
256:
532-535,
1992
6.
Bychkov, R.,
M. Gollasch,
C. Ried,
F. C. Luft,
and
H. Haller.
Regulation of spontaneous transient outward potassium currents in human coronary arteries.
Circulation
95:
503-510,
1997
7.
Davis, R. J.,
B. R. Ganong,
R. M. Bell,
and
M. P. Czech.
sn-1,2-Dioctanoylglycerol. A cell-permeable diacylglycerol that mimics phorbol diester action on the epidermal growth factor receptor and mitagenesis.
J. Biol. Chem.
260:
1562-1566,
1985
8.
Fan, S. F.,
and
C. Y. Kao.
On the apparent absence of maxi-K+ channel in rat aortic myocyte.
Proc. Soc. Exp. Biol. Med.
202:
465-469,
1993[Abstract].
9.
Galvez, A.,
G. Gimenez Gallego,
J. P. Reuben,
L. Roy Contancin,
P. Feigenbaum,
G. J. Kaczorowski,
and
M. L. Garcia.
Purification and characterization of a unique, potent, peptidyl probe for the high conductance calcium-activated potassium channel from venom of the scorpion Buthus tamulus.
J. Biol. Chem
265:
11083-11090,
1990
10.
Giangiacomo, K. M.,
M. L. Garcia,
and
O. B. McManus.
Mechanism of iberiotoxin block of the large-conductance calcium-activated potassium channel from bovine aortic smooth muscle.
Biochemistry
31:
6719-6727,
1992[Medline].
11.
Hopp, H.-H.,
R. Schubert,
V. N. Serebryakov,
and
H. Mewes.
The level of the spontaneous myogenic tone of rat tail resistance arteries is determined by protein kinase A activation of Ca-activated K-channels (Abstract).
Pflügers Arch.
429:
R72,
1995.
12.
Karibe, A.,
J. Watanabe,
S. Horiguchi,
M. Takeuchi,
S. Suzuki,
M. Funakoshi,
H. Katoh,
M. Keitoku,
S. Satoh,
and
K. Shirato.
Role of cytosolic Ca and protein kinase C in developing myogenic contraction in isolated rat small arteries.
Am. J. Physiol.
272 (Heart Circ. Physiol. 41):
H1165-H1172,
1997
13.
Kitamura, K.,
Z. L. Xiong,
N. Teramoto,
and
H. Kuriyama.
Roles of inositol trisphosphate and protein kinase-C in the spontaneous outward current modulated by calcium release in rabbit portal vein.
Pflügers Arch.
421:
539-551,
1992[Medline].
14.
Kobayashi, E.,
H. Nakano,
M. Morimoto,
and
T. Tamaoki.
Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C.
Biochem. Biophys. Res. Commun.
159:
548-553,
1989[Medline].
15.
Lee, M. W.,
and
D. L. Severson.
Signal transduction in vascular smooth muscle: diacylglycerol second messengers and PKC action.
Am. J. Physiol.
267 (Cell Physiol. 36):
C659-C678,
1994
16.
Lepretre, N.,
and
J. Mironneau.
Alpha(2)-adrenoceptors activate dihydropyridine-sensitive calcium channels via Gi-proteins and protein kinase C in rat portal vein myocytes.
Pflügers Arch.
429:
253-261,
1994[Medline].
17.
Li, P. L.,
and
W. B. Campbell.
Epoxyeicosatrienoic acids activate K+ channels in coronary smooth muscle through a guanine nucleotide binding protein.
Circ. Res.
80:
877-884,
1997
18.
Minami, K.,
K. Fukuzawa,
and
Y. Nakaya.
Protein kinase-C inhibits the Ca2+-activated K+ channel of cultured porcine coronary artery smooth muscle cells.
Biochem. Biophys. Res. Commun.
190:
263-269,
1993[Medline].
19.
Nelson, M. T.,
H. Cheng,
M. Rubart,
L. F. Santana,
A. D. Bonev,
H. J. Knot,
and
W. J. Lederer.
Relaxation of arterial smooth muscle by calcium sparks.
Science
270:
633-637,
1995
20.
Robertson, B. E.,
R. Schubert,
J. Hescheler,
and
M. T. Nelson.
cGMP-dependent protein kinase activates Ca-activated K channels in cerebral artery smooth muscle cells.
Am. J. Physiol.
265 (Cell Physiol. 34):
C299-C303,
1993
21.
Schubert, R.
Multiple ligand-ion solutions: a guide for solution preparation and computer program understanding.
J. Vasc. Res.
33:
86-98,
1996[Medline].
22.
Schubert, R.,
V. N. Serebryakov,
H. Engel,
and
H.-H. Hopp.
Iloprost activates KCa channels of vascular smooth muscle cells: role of cAMP-dependent protein kinase.
Am. J. Physiol.
271 (Cell Physiol. 40):
C1203-C1211,
1996
23.
Schubert, R.,
V. N. Serebryakov,
H. Mewes,
and
H.-H. Hopp.
Iloprost dilates rat small arteries: role of KATP- and KCa-channel activation by cAMP-dependent protein kinase.
Am. J. Physiol.
272 (Heart Circ. Physiol. 41):
H1147-H1156,
1997
24.
Shipston, M. J.,
and
D. L. Armstrong.
Activation of protein kinase C inhibits calcium-activated potassium channels in rat pituitary tumor cells.
J. Physiol. (Lond.)
493:
665-672,
1996[Medline].
25.
Shoemaker, R. L.,
and
R. T. Worrell.
Ca2(+)-sensitive K+ channel in aortic smooth muscle of rats.
Proc. Soc. Exp. Biol. Med.
196:
325-332,
1991[Abstract].
26.
Tateishi, J.,
and
J. E. Faber.
ATP-sensitive K+ channels mediate alpha(2D)-adrenergic receptor contraction of arteriolar smooth muscle and reversal of contraction by hypoxia.
Circ. Res.
76:
53-63,
1995
27.
VanRenterghem, B.,
M. D. Browning,
and
J. L. Maller.
Regulation of mitogen-activated protein kinase activation by protein kinases A and C in a cell-free system.
J. Biol. Chem.
269:
24666-24672,
1994
28.
White, R. E.,
D. J. Darkow,
and
J. L. F. Lang.
Estrogen relaxes coronary arteries by opening BKCa channels through a cGMP-dependent mechanism.
Circ. Res.
77:
936-942,
1995
29.
Zhang, H.,
B. Weir,
and
E. E. Daniel.
Activation of protein kinase C inhibits potassium currents in cultured endothelial cells.
Pharmacology
50:
247-256,
1995[Medline].
30.
Zou, A. P.,
J. T. Fleming,
J. R. Falck,
E. R. Jacobs,
D. Gebremedhin,
D. R. Harder,
and
R. J. Roman.
20-HETE is an endogenous inhibitor of the large-conductance Ca2+-activated K+ channel in renal arterioles.
Am. J. Physiol.
270 (Regulatory Integrative Comp. Physiol. 39):
R228-R237,
1996
This article has been cited by other articles:
![]() |
J. Ledoux, M. E. Werner, J. E. Brayden, and M. T. Nelson Calcium-Activated Potassium Channels and the Regulation of Vascular Tone Physiology, February 1, 2006; 21(1): 69 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Barman, S. Zhu, and R. E. White PKC activates BKCa channels in rat pulmonary arterial smooth muscle via cGMP-dependent protein kinase Am J Physiol Lung Cell Mol Physiol, June 1, 2004; 286(6): L1275 - L1281. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Barman, S. Zhu, and R. E. White Protein kinase C inhibits BKCa channel activity in pulmonary arterial smooth muscle Am J Physiol Lung Cell Mol Physiol, January 1, 2004; 286(1): L149 - L155. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Hagen, O. Bayguinov, and K. M. Sanders {beta}1-Subunits are required for regulation of coupling between Ca2+ transients and Ca2+-activated K+ (BK) channels by protein kinase C Am J Physiol Cell Physiol, November 1, 2003; 285(5): C1270 - C1280. [Abstract] [Full Text] [PDF] |
||||